Related references
Note: Only part of the references are listed.The current status of artisanal cannabis for the treatment of epilepsy in the United States
Dustin Sulak et al.
EPILEPSY & BEHAVIOR (2017)
Cannabinoids in treatment-resistant epilepsy: A review
Brooke K. O'Connell et al.
EPILEPSY & BEHAVIOR (2017)
Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys
William S. John et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers
Shanna Babalonis et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Neural correlates of interactions between cannabidiol and (9)-tetrahydrocannabinol in mice: implications for medical cannabis
S. M. Todd et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors
A. G. Sartim et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys
Lance R. McMahon
DRUG AND ALCOHOL DEPENDENCE (2016)
Sex-dependent effects of cannabis-induced analgesia
Ziva D. Cooper et al.
DRUG AND ALCOHOL DEPENDENCE (2016)
Acute and Chronic Effects of Cannabidiol on Δ9-Tetrahydrocannabinol (Δ9-THC)-Induced Disruption in Stop Signal Task Performance
David S. Jacobs et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2016)
Are IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study
C. Mokrysz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Inhaled delivery of Δ9-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology
Jacques D. Nguyen et al.
NEUROPHARMACOLOGY (2016)
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies
Nicholas J. Jackson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Delta(9)-tetrahydrocannabinol in Sprague-Dawley rats
Michael A. Taffe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption
Cristina A. J. Stern et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Endocannabinoid signalling in reward and addiction
Loren H. Parsons et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse
Zuzana Justinova et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Further human evidence for striatal dopamine release induced by administration of a†9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G. Bossong et al.
PSYCHOPHARMACOLOGY (2015)
A systematic review of the antipsychotic properties of cannabidiol in humans
Tabitha A. Iseger et al.
SCHIZOPHRENIA RESEARCH (2015)
Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The case for medical marijuana in epilepsy
Edward Maa et al.
EPILEPSIA (2014)
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
M. V. Fogaca et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior
Mirella Nardo et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2014)
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model
Timothy W. Lefever et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part II: Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents
Laurie A. Manwell et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
M. Jerry Wright et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity
Vicky Katsidoni et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Spicing things up: synthetic cannabinoids
Max Spaderna et al.
PSYCHOPHARMACOLOGY (2013)
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors
Felipe V. Gomes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol?
Daniel Kleinloog et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
Cristina A. J. Stern et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Δ9-TETRAHYDROCANNABINOL ATTENUATES MDMA-INDUCED HYPERTHERMIA IN RHESUS MONKEYS
M. A. Taffe
NEUROSCIENCE (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Persistent cannabis users show neuropsychological decline from childhood to midlife
Madeline H. Meier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
C. J. A. Morgan et al.
PSYCHOLOGICAL MEDICINE (2012)
Interaction between cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
Antonio Waldo Zuardi et al.
PSYCHOPHARMACOLOGY (2012)
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
Sabatino Maione et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Plasma Cannabinoid Pharmacokinetics following Controlled Oral Delta(9)-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration
Erin L. Karschner et al.
CLINICAL CHEMISTRY (2011)
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
E. L. Karschner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Heterogeneity in the composition of marijuana seized in California
James Richard Burgdorf et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Sativex®(tetrahydrocannabinol + cannabidiol), an endocannabinoid system modulator: basic features and main clinical data
Patrick Vermersch
Expert Review of Neurotherapeutics (2011)
Synthetic delta-9-tetrahydrocannabinol elicits schizophrenia-like negative symptoms which are distinct from sedation
P. D. Morrison et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2011)
Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: Implications for endocannabinoid control of hippocampal neural plasticity
Robert E. Hampson et al.
NEUROPHARMACOLOGY (2011)
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential
Andreas M. Stadelmann et al.
NEUROSCIENCE LETTERS (2011)
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
Charlotte Klein et al.
PSYCHOPHARMACOLOGY (2011)
Cannabis with high cannabidiol content is associated with fewer psychotic experiences
Christian D. Schubart et al.
SCHIZOPHRENIA RESEARCH (2011)
Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells
Qiang Li et al.
BRAIN RESEARCH (2010)
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation
I. Magen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal models of cannabinoid reward
Leigh V. Panlilio et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Retrograde Endocannabinoid Signaling Reduces GABAergic Synaptic Transmission to Gonadotropin-Releasing Hormone Neurons
Imre Farkas et al.
ENDOCRINOLOGY (2010)
Modulation of effective connectivity during emotional processing by Δ9-tetrahydrocannabinol and cannabidiol
Paolo Fusar-Poli et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
Luciano De Petrocellis et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Central nervous system effects of haloperidol on THC in healthy male volunteers
Marieke Liem-Moolenaar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Celia J. A. Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
Leonardo B. M. Resstel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
Daniel Thomas Malone et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
P. D. Morrison et al.
PSYCHOLOGICAL MEDICINE (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Stress-related factors in cannabis use and misuse: Implications for prevention and treatment
Scott M. Hyman et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Stefan J. Borgwardt et al.
BIOLOGICAL PSYCHIATRY (2008)
Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats
Michael S. Smirnov et al.
BRAIN RESEARCH (2008)
Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
Kazuhide Hayakawa et al.
BRAIN RESEARCH (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
CB2 receptors in the brain: role in central immune function
G. A. Cabral et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2008)
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
Robert E. Vann et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
Marilyn A. Huestis et al.
PSYCHOPHARMACOLOGY (2007)
Endocannabinoids and synaptic function in the CNS
Yuki Hashimotodani et al.
NEUROSCIENTIST (2007)
Cannabidiol - Recent advances
Raphael Mechoulam et al.
CHEMISTRY & BIODIVERSITY (2007)
The acute effects of cannabinoids on memory in humans: a review
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2006)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Cannabidiol monotherapy for treatment-resistant schizophrenia
Antonio Waldo Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Interactions between THC and cannabidiol in mouse models of cannabinoid activity
SA Varvel et al.
PSYCHOPHARMACOLOGY (2006)
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo et al.
MEDICAL HYPOTHESES (2006)
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract
T Nadulski et al.
THERAPEUTIC DRUG MONITORING (2005)
SR 141716A differentially attenuates the behavioral effects of Δ9-THC in rhesus monkeys
LR McMahon et al.
BEHAVIOURAL PHARMACOLOGY (2005)
CB1 cannabinoid receptor-mediated modulation of food intake in mice
JL Wiley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Self-administration of cannabinoids by experimental animals and human marijuana smokers
Z Justinova et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain
DP Finn et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Differential effects of THC or CBD-rich cannabis extracts on working memory in rats
P Fadda et al.
NEUROPHARMACOLOGY (2004)
Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2003)
A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
DT Wade et al.
CLINICAL REHABILITATION (2003)
Cannabidiol: An overview of some pharmacological aspects
R Mechoulam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Metabolic mapping of the time-dependent effects of Δ9-tetrahydrocannabinol administration in the rat
CT Whitlow et al.
PSYCHOPHARMACOLOGY (2002)
Neuroscience - Endocannabinoid signaling in the brain
RI Wilson et al.
SCIENCE (2002)
Endocannabinoids in cognition and dependence
AH Lichtman et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Reduced binocular depth inversion in schizophrenic patients
U Schneider et al.
SCHIZOPHRENIA RESEARCH (2002)
Effects of acute smoked marijuana on complex cognitive performance
CL Hart et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The pharmacological activity of inhalation exposure to marijuana smoke in mice
AH Lichtman et al.
DRUG AND ALCOHOL DEPENDENCE (2001)
Cannabinoid-induced alterations in brain disposition of drugs of abuse
MJ Reid et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Pharmacological evaluation of aerosolized cannabinoids in mice
AH Lichtman et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Different effects of nabilone and cannabidiol on binocular depth inversion in man
FM Leweke et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Share Paper
